CD5 is highly expressed in T-ALL and T-cell lymphoma in addition to a fraction of B cell malignancies [4–6], such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), rather than hematopoietic stem cells and natural killer (NK) cells [7]. Here, CD5 is linked to mantle cell lymphoma.